GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
Molecular Dx Has Your (Copy) Number
CNV Detection and Analysis Tools Are Being Used To Fill Genetic Diagnostic Gaps
GSK China Scandal
Chinese officials have detained 22 GlaxoSmithKline (GSK) employees and an unknown number of doctors in the last month, accusing them of misdeeds and bribery. The company is one of about 60 biopharmas currently under investigation by Beijing for pricing policies. (Learn more here.) Do you expect this scandal will have a lasting effect on China’s biopharma industry?